Advertisement

Topics

Bioverativ and Invicro Enter Imaging Collaboration to Improve Management of Joint Health in Hemophilia Patients

14:08 EDT 24 Aug 2017 | Speciality Pharma Journal

WALTHAM, Mass. & BOSTON–(BUSINESS WIRE)–Bioverativ Inc. (NASDAQ: BIVV), a global biotechnology company focused on the discovery, development and commercialization of innovative therapies for hemophilia and other rare blood disorders, and Invicro, LLC, a leading provider of imaging services and analysis for pharmaceutical research and development, today announced that they have formed a strategic collaboration focused on …

Original Article: Bioverativ and Invicro Enter Imaging Collaboration to Improve Management of Joint Health in Hemophilia Patients

NEXT ARTICLE

More From BioPortfolio on "Bioverativ and Invicro Enter Imaging Collaboration to Improve Management of Joint Health in Hemophilia Patients"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotechnology
Antibodies Antisense Assays Biochips Bioinformatics Biological Therapy Biomarkers Biomaterials Bioscience Cell Culture Cloning Cytokine Diagnostics Dna Extraction Dna Sequencing Dna Transform...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...